Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 May 11;134(2):531–541. doi: 10.1007/s10549-012-2081-x

Figure 3.

Figure 3

Analysis of anti-SGK3 antibody for IHC. Parental 293T cells and those transiently expressing activated SGK3 (SGK3 OXP, top) or an shRNA sequence against SGK3 (SGK3 KD, bottom) were harvested and used for IHC analysis.

HHS Vulnerability Disclosure